{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:06:27Z","timestamp":1757624787714,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.josat.2022.208940","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T20:42:30Z","timestamp":1673037750000},"page":"208940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Variation in Nevada primary care clinicians' use of urine drug testing to mitigate opioid harm"],"prefix":"10.1016","volume":"145","author":[{"given":"Sarah Y.T.","family":"Hartzell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle S.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine Michelle","family":"Albertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalyn","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.josat.2022.208940_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1370\/afm.1242","article-title":"Racial differences in primary care opioid risk reduction strategies","volume":"9","author":"Becker","year":"2011","journal-title":"Annals of Family Medicine"},{"issue":"6","key":"10.1016\/j.josat.2022.208940_bb0015","first-page":"E1","article-title":"A better approach to opioid prescribing in primary care","volume":"63","author":"Canada","year":"2014","journal-title":"The Journal of Family Practice"},{"issue":"1","key":"10.1016\/j.josat.2022.208940_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/08897077.2015.1132293","article-title":"Primary care providers' experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic noncancer pain patients in safety net health care settings","volume":"37","author":"Ceasar","year":"2016","journal-title":"Substance Abuse"},{"issue":"4","key":"10.1016\/j.josat.2022.208940_bb0030","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/SLA.0000000000003013","article-title":"Provider characteristics associated with outpatient opioid prescribing after surgery","volume":"271","author":"Cron","year":"2020","journal-title":"Annals of Surgery"},{"issue":"15","key":"10.1016\/j.josat.2022.208940_bb0035","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.josat.2022.208940_bb0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/pm\/pnz005","article-title":"Differences in opioid prescribing among generalist physicians, nurse practitioners, and physician assistants","volume":"21","author":"Ellenbogen","year":"2020","journal-title":"Pain Medicine"},{"issue":"7","key":"10.1016\/j.josat.2022.208940_bb0050","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jpain.2007.02.432","article-title":"Substance use disorders in primary care sample receiving daily opioid therapy","volume":"8","author":"Fleming","year":"2007","journal-title":"The Journal of Pain"},{"issue":"14","key":"10.1016\/j.josat.2022.208940_bb0055","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1080\/10826084.2020.1805467","article-title":"Urine drug testing among opioid-na\u00efve and long-term opioid Nevada medicaid beneficiaries","volume":"55","author":"Friedman","year":"2020","journal-title":"Substance Use & Misuse"},{"issue":"5","key":"10.1016\/j.josat.2022.208940_bb0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use gisorders in U.S. adults: 2015 national survey on drug use and health","volume":"167","author":"Han","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2022.208940_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pain.2012.07.034","article-title":"Racial disparities in the monitoring of patients on chronic opioid therapy","volume":"154","author":"Hausmann","year":"2013","journal-title":"PAIN\u00ae"},{"key":"10.1016\/j.josat.2022.208940_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1472-6963-6-46","article-title":"Predictors of opioid misuse in patients with chronic pain: A prospective cohort study","volume":"6","author":"Ives","year":"2006","journal-title":"BMC Health Services Research"},{"issue":"4","key":"10.1016\/j.josat.2022.208940_bb0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/jalm.2017.023341","article-title":"Executive summary: American Association of Clinical Chemistry Laboratory Medicine Practice Guideline-Using clinical laboratory tests to monitor drug therapy in pain management patients","volume":"2","author":"Jannetto","year":"2018","journal-title":"The Journal of Applied Laboratory Medicine"},{"issue":"1","key":"10.1016\/j.josat.2022.208940_bb0080","first-page":"33","article-title":"Urine drug tests: Ordering and interpretation","volume":"99","author":"Kale","year":"2019","journal-title":"American Family Physician"},{"issue":"9","key":"10.1016\/j.josat.2022.208940_bb0085","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1080\/10826084.2021.1926514","article-title":"How do clinicians of different specialties perceive and use opioid risk mitigation strategies? A qualitative study","volume":"56","author":"Keller","year":"2021","journal-title":"Substance Use & Misuse"},{"author":"KFF","key":"10.1016\/j.josat.2022.208940_bb0090"},{"key":"10.1016\/j.josat.2022.208940_bb0095","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.36076\/ppj.2017.s145","article-title":"Repeated quantitative urine toxicology analysis may improve chronic pain patient compliance with opioid therapy","volume":"20","author":"Knezevic","year":"2017","journal-title":"Pain Physician"},{"issue":"11","key":"10.1016\/j.josat.2022.208940_bb0100","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jpain.2014.08.006","article-title":"Barriers to guideline-concordant opioid management in primary care\u2014A qualitative study","volume":"15","author":"Krebs","year":"2014","journal-title":"The Journal of Pain"},{"issue":"5","key":"10.1016\/j.josat.2022.208940_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5055\/jom.2017.0407","article-title":"Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in Food and Drug Administration's sentinel system","volume":"13","author":"Larochelle","year":"2017","journal-title":"Journal of Opioid Management"},{"issue":"10","key":"10.1016\/j.josat.2022.208940_bb9000","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s11606-021-07095-8","article-title":"Do urine drug tests reveal substance misuse among patients prescribed opioids for chronic pain?","volume":"37","author":"Larochelle","year":"2021","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2022.208940_bb0110","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1007\/s11606-020-05823-0","article-title":"Opioid prescribing by primary care providers: A cross-sectional analysis of nurse practitioners, physician assistant, and physician prescribing patterns","volume":"35","author":"Lozada","year":"2020","journal-title":"Journal of General Internal Medicine"},{"issue":"3 Suppl","key":"10.1016\/j.josat.2022.208940_bb0115","first-page":"S67","article-title":"American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2\u2013Guidance","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.josat.2022.208940_bb0125","unstructured":"NRS: 639.1373, n.d.NRS: 639.1373. (n.d.). Nevada professions, occupations, and businesses: Sec. 639.1373. Retrieved from https:\/\/www.leg.state.nv.us\/NRS\/NRS639.html#NRS639Sec1373 Accessed March 28,2022."},{"issue":"1","key":"10.1016\/j.josat.2022.208940_bb0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7326\/0003-4819-160-1-201401070-00732","article-title":"Opioid prescribing: A systematic review and critical appraisal of guidelines for chronic pain","volume":"160","author":"Nuckols","year":"2014","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1016\/j.josat.2022.208940_bb0135","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jpsychores.2012.02.009","article-title":"Dynamic risk factors in the misuse of opioid analgesics","volume":"72","author":"Pergolizzi","year":"2012","journal-title":"Journal of Psychosomatic Research"},{"issue":"6","key":"10.1016\/j.josat.2022.208940_bb0140","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1533-2500.2010.00375.x","article-title":"The role of urine drug testing for patients on opioid therapy","volume":"10","author":"Pergolizzi","year":"2010","journal-title":"Pain Practice"},{"issue":"6","key":"10.1016\/j.josat.2022.208940_bb0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5055\/jom.2007.0022","article-title":"Family physicians\u2019 proficiency in urine drug test interpretation","volume":"3","author":"Reisfield","year":"2007","journal-title":"Journal of Opioid Management"},{"issue":"1","key":"10.1016\/j.josat.2022.208940_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08897077.2019.1621239","article-title":"Does the perceived accuracy of urine drug testing impact clinical decision-making?","volume":"41","author":"Rosenfeld","year":"2020","journal-title":"Substance Abuse"},{"issue":"6","key":"10.1016\/j.josat.2022.208940_bb0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5055\/jom.2016.0358","article-title":"Evaluation of treatment changes following electronic consultation to a pharmacist-run urine drug testing service in a veterans healthcare system","volume":"12","author":"Stammet","year":"2016","journal-title":"Journal of Opioid Management"},{"issue":"9","key":"10.1016\/j.josat.2022.208940_bb0160","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s11606-011-1648-2","article-title":"Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain","volume":"26","author":"Starrels","year":"2011","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2022.208940_bb0165","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/1475-6773.12663","article-title":"Perspectives: Using results from HRSA's health workforce simulation model to examine the geography of primary care","volume":"52","author":"Streeter","year":"2017","journal-title":"Health Services Research"},{"issue":"2","key":"10.1016\/j.josat.2022.208940_bb0170","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pain.2010.05.020","article-title":"Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP study","volume":"150","author":"Sullivan","year":"2010","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.josat.2022.208940_bb0175","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.amepre.2020.10.011","article-title":"Trends in urine drug testing among long-term opioid users, 2012\u20132018","volume":"60","author":"Taha","year":"2021","journal-title":"American Journal of Preventive Medicine"},{"issue":"6","key":"10.1016\/j.josat.2022.208940_bb0180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/AJP.0b013e31816b1070","article-title":"Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis","volume":"24","author":"Turk","year":"2008","journal-title":"The Clinical Journal of Pain"},{"key":"10.1016\/j.josat.2022.208940_bb0185","first-page":"305","article-title":"Chronic opioid therapy risk reduction initiative: Impact on urine drug testing rates and results","volume":"29","author":"Turner","year":"2014","journal-title":"Journal of Internal Medicine"},{"issue":"1\u20132","key":"10.1016\/j.josat.2022.208940_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","article-title":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review","volume":"131","author":"van Boekel","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.josat.2022.208940_bb0195","first-page":"1","article-title":"Physician workforce in the United States of America: Forecasting nationwide shortages","volume":"18","author":"Zhang","year":"2020","journal-title":"Human Resources for Health"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294987592200011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294987592200011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:49:13Z","timestamp":1757432953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S294987592200011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":36,"alternative-id":["S294987592200011X"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2022.208940","relation":{},"ISSN":["2949-8759"],"issn-type":[{"type":"print","value":"2949-8759"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variation in Nevada primary care clinicians' use of urine drug testing to mitigate opioid harm","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2022.208940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"208940"}}